Sopharma AD notifies that for February 2018 the Company recorded an increase of sales revenues of 2% compared to the same month of 2017, including 8% increase of domestic sales and same level of export sales.

For the first two months of this year, revenues from sales increased by 1% compared to the same period of 2017, including 2% increase of export sales and same level of domestic sales.

Sopharma Group reported for the first time over BGN 1 billion in sales revenue for 2017, marking an increase of 15.9%. Over the same period, the Group achieved a 25.4% increase in operating profit, a 17.5% increase in EBITDA. Net profit declined by 16.1% due to the lack of one-off transactions that resulted in extremely high financial revenues as they were in 2016.